1. Home
  2. GBIO vs CDTG Comparison

GBIO vs CDTG Comparison

Compare GBIO & CDTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • CDTG
  • Stock Information
  • Founded
  • GBIO 2016
  • CDTG 2012
  • Country
  • GBIO United States
  • CDTG China
  • Employees
  • GBIO 115
  • CDTG N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • CDTG
  • Sector
  • GBIO Health Care
  • CDTG
  • Exchange
  • GBIO Nasdaq
  • CDTG NYSE
  • Market Cap
  • GBIO 29.2M
  • CDTG 24.5M
  • IPO Year
  • GBIO 2020
  • CDTG 2024
  • Fundamental
  • Price
  • GBIO $0.36
  • CDTG $0.66
  • Analyst Decision
  • GBIO Strong Buy
  • CDTG
  • Analyst Count
  • GBIO 4
  • CDTG 0
  • Target Price
  • GBIO $7.33
  • CDTG N/A
  • AVG Volume (30 Days)
  • GBIO 493.7K
  • CDTG 748.6K
  • Earning Date
  • GBIO 05-07-2025
  • CDTG 07-03-2025
  • Dividend Yield
  • GBIO N/A
  • CDTG N/A
  • EPS Growth
  • GBIO N/A
  • CDTG N/A
  • EPS
  • GBIO N/A
  • CDTG 0.72
  • Revenue
  • GBIO $24,556,000.00
  • CDTG $31,432,824.00
  • Revenue This Year
  • GBIO N/A
  • CDTG N/A
  • Revenue Next Year
  • GBIO $10.90
  • CDTG N/A
  • P/E Ratio
  • GBIO N/A
  • CDTG $0.98
  • Revenue Growth
  • GBIO 146.47
  • CDTG N/A
  • 52 Week Low
  • GBIO $0.32
  • CDTG $0.52
  • 52 Week High
  • GBIO $4.34
  • CDTG $4.64
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 39.03
  • CDTG N/A
  • Support Level
  • GBIO $0.36
  • CDTG N/A
  • Resistance Level
  • GBIO $0.41
  • CDTG N/A
  • Average True Range (ATR)
  • GBIO 0.04
  • CDTG 0.00
  • MACD
  • GBIO -0.00
  • CDTG 0.00
  • Stochastic Oscillator
  • GBIO 9.09
  • CDTG 0.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About CDTG CDT ENVIRONMENTAL TECH INV HLDG LTD

CDT Environmental Technology Investment Holdings Ltd is a waste treatment company. The company generates revenue through the design, development, manufacture, sales, installation, operation and maintenance of sewage treatment systems and by providing sewage treatment services. It engages in two business lines namely, rural sewage treatment and septic tank treatment in both urban and rural areas.

Share on Social Networks: